AMCP In The News July 2, 2024 Managed Healthcare Executive Access to Prescription Digital Therapeutics Act of 2023
AMCP In The News July 2, 2024 MobiHealthNews Q&A: The status of the Access to Prescription Digital Therapeutics Act
AMCP In The News July 2, 2024 Pharmaphorum Prescription digital therapeutics show tremendous promise to improve - and save - lives
AMCP In The News July 2, 2024 Specialty Pharmacy Continuum Vial Size Rounding for Oncology Drugs Achieves Significant Savings for N.J. Health Plan Syndicated in: Pharmacy Practice News
AMCP In The News July 2, 2024 American Journal of Managed Care Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs? Specialty Pharmacy
AMCP In The News July 2, 2024 American Journal of Managed Care Dr Yuqian Liu Investigates the Future Benefits of Cell, Gene Therapies Using Real-World Data Specialty Pharmacy
AMCP In The News July 2, 2024 Managed Healthcare Executive Do P&T Committees Need Help With Cell and Gene Therapy? | AMCP 2024 Specialty Pharmacy
AMCP In The News July 2, 2024 American Journal of Managed Care: The Center for Biosimilars Adam Colborn Reviews Biosimilar Interchangeability Requirements, Advocates for Pharmacist Resources Read more on Biosimilar Interchangeability Requirements and Pharmacist Resources Biosimilars
Legislative & Regulatory Briefings June 19, 2024 AMCP Legislative Regulatory Briefing June 2024 Legislation & Regulation, Medicare
